Chinaʼs CSAR Cosmetic Regulation: Compliance Guide

What is CSAR China cosmetic regulation?

The Cosmetic Supervision and Administration Regulation (CSAR) is the framework that reshaped cosmetic supervision in China. It was promulgated in 2020 and took effect on 1 January 2021, replacing the previous administrative framework with a broader lifecycle approach.

Its purpose is to strengthen the quality, safety, and supervision of cosmetics sold in China. In practice, CSAR China does not stop at registration or filing. It also covers raw materials, labeling, efficacy test, safety assessment, manufacturing, and post-market responsibilities (source: Cosmetics Obs).

It notably frames:

product registration and filing
ingredient management
efficacy test
safety assessment
manufacturing and marketing supervision
post-market obligations

The official authority in charge is the NMPA (National Medical Products Administration).

CSAR China in 5 key points

It took effect on 1 January 2021.
It applies a lifecycle approach to cosmetic supervision.
It distinguishes between special cosmetics and general cosmetics.
It strengthens oversight of ingredients and new cosmetic ingredients.
It formalizes safety assessment requirements, with a key transition threshold on 1 May 2025.

Source: NMPA (National Medical Products Administration), Cosmetic Supervision and Administration Regulation, 2021

The core principles behind Chinaʼs CSAR

CSAR China is built around three major pillars:

1. Clearer product classification

Under Chinaʼs CSAR, cosmetics are handled through registration or filing depending on category, with different requirements for special cosmetics, general cosmetics, and new cosmetic ingredients. Overseas applicants must also designate a domestic responsible person in China.

2. Stronger ingredient control

Chinaʼs new cosmetic regulation CSAR reinforces control over raw materials and ingredient data. The NMPA implementation notice requires ingredient source information, and broader safety-related information for all ingredients with supplementary obligations for existing products.

3. Formalized safety assessment

Safety assessment is now a core compliance pillar. The NMPA issued optimization measures confirming that some qualified general cosmetics may submit the basic conclusions of the safety assessment, while keeping the full report on file.

The simplified report route for certain applications remained available only until 1 May 2025.

Chinaʼs CSAR main implementation milestones (2021–2025)

The rollout of CSAR China cosmetic regulation has been phased over time. Key milestones include:

May 2021: new format for China cosmetic registration and filing dossiers
May 2022: update of existing dossiers and publication of efficacy summaries
January 2023: new obligations relating to raw material safety-related information
May 2023: supplementary dossier updates for existing products under the new framework
May 2025: end of the transition period for simplified safety assessment reporting under CSAR

This phased implementation has made China cosmetic dossier management more complex, especially for brands already active on the market before the post-CSAR framework was fully operational.

What CSAR China changes for cosmetic companies

CSAR China cosmetic regulation significantly increases the responsibility of companies placing cosmetic products on the Chinese market.

Main changes include:

more rigorous safety requirements
stricter efficacy test expectations
greater transparency on cosmetic products and manufacturing
centralized management of ingredient-related data
stronger post-market supervision

CSAR China broadens the responsibility of importers, manufacturers, registrants, and filing entities. Cosmetic compliance in China must be maintained throughout the productʼs lifecycle, not checked only at the time of export or first filing.

In the event of non-compliance, sanctions may include:

product recall or withdrawal
suspension of registration or filing activities
administrative penalties
broader market consequences depending on the breach and the operatorʼs obligations under the framework

Cosmetic compliance in China: strategic points of vigilance

To secure cosmetic market access in China, several elements are critical:

early validation of ingredient acceptability under Chinese cosmetic requirements
consistency between marketing claims and efficacy substantiation
a properly structured China cosmetic registration or filing dossier
a documented and compliant safety assessment strategy
ongoing regulatory watch

Chinaʼs CSAR is an evolving framework. One-time compliance is not enough. Compliance has to be maintained over time.

ALPOL Cosmetiqueʼs regulatory support

In this demanding context, regulatory control becomes a strategic lever.

ALPOL Cosmetique supports brands through:

an integrated Regulatory Affairs function
continuous international regulatory monitoring
expertise in assessing export compliance for China

This support may include:

formula compliance analysis
ingredient list verification
support on CSAR safety assessment requirements
consistency checks between claims and dossier logic

The objective is to integrate regulatory requirements upstream in product development in order to secure cosmetic market access in China within a controlled and compliant framework.

Key points to remember

CSAR China regulates the full lifecycle of cosmetic products
CSAR China entered into force on 1 January 2021
Safety assessment requirements have been reinforced, with a key transition ending on 1 May 2025
Efficacy substantiation expectations are stricter
The responsibility of market operators has been expanded
Cosmetic compliance in China must be maintained over time

FAQ on Chinaʼs CSAR

Are you developing a product for the Chinese market?

In a regulatory environment as structured as CSAR China cosmetic regulation, anticipation and documentary rigor are critical.

Contact ALPOL Cosmetique to secure your regulatory compliance strategy and structure your China cosmetics export project within a controlled framework.

Contact us